How Does Boston Scientific Get To $12 Billion Sales In 2020: Rhythm & Neuro Or Cardiovascular?
- Monday, March 9, 2020, 7:17
- Market
- Add a comment
We estimate Boston Scientific’s (NYSE: BSX) 2020 sales to be around $12 billion, driven by the company’s cardiovascular segment. Boston Scientific’s cardiovascular business will account for roughly 40% of the company’s total revenue in 2020, and it will also grow at a faster pace compared…
About the Author
admin123 has written 23449 stories on this site.
